Dr Yung-Yao Lin
Senior Lecturer
Centre for Genomics and Child Health, Blizard Institute
Queen Mary University of London
Queen Mary University of London
Research
Human induced pluripotent stem cells, CRISPR genome editing, Neuromuscular disorders, Disease modelling, Regenerative medicine, Tissue engineering
Interests
Research in the Lin group is focused on muscular dystrophy and mechanisms regulating muscle regeneration. His work has brought novel insights into the pathological mechanisms underlying some types of muscular dystrophy. The Lin group has established essential expertise in generation and differentiation of human induced pluripotent stem cells (iPSCs) and CRISPR-mediated genome manipulation technology. We are interested in integrating human iPSC and Organ-on-a-Chip technologies to enable neuromuscular research in health and disease, as well as drug discovery.Publications
2025
Engineered human myogenic cells in hydrogels generate innervated vascularized myofibers within dystrophic mouse muscle on long-term engraftmentKowala A, Boot J, Meng J, Mein CA, Pourquié O, Connelly JT, Morgan JE, Lin Y-Y
Cell Reports Medicine, Elsevier Bv vol. 6 (3), 102019-102019.
01-03-2025
2023
Engineered human myogenic cells in hydrogels generate functional myofibers within dystrophic mouse muscleKowala A, Meng J, Pourquié O, Connelly J, Morgan JE, Lin Y-Y
In Cold Spring Harbor Laboratory
05-09-2023
3D Compartmentalised Human Pluripotent Stem Cell–derived Neuromuscular Co-culturesHarley P, Paredes-Redondo A, Grenci G, Viasnoff V, Lin Y, Lieberam I
Bio-Protocol, Bio-Protocol, Llc vol. 13 (5)
01-01-2023
2022
CRISPR-mediated correction of skeletal muscle Ca2+ handling in a novel DMD patient-derived pluripotent stem cell modelMorera C, Kim J, Paredes-Redondo A, Nobles M, Rybin D, Moccia R, Kowala A, Meng J et al.
Neuromuscular Disorders, Elsevier Bv vol. 32 (11-12), 908-922.
01-12-2022
CRISPR-mediated correction of skeletal muscle Ca2+handling in a novel DMD patient-derived pluripotent stem cell modelMorera C, Kim J, Paredes-Redondo A, Nobles M, Rybin D, Moccia R, Kowala A, Meng J et al.
In Cold Spring Harbor Laboratory
18-02-2022
Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophyChesshyre M, Ridout D, Hashimoto Y, Ookubo Y, Torelli S, Maresh K, Ricotti V, Abbott L et al.
Journal of Cachexia, Sarcopenia and Muscle, Wiley vol. 13 (2), 1360-1372.
26-01-2022
2021
Comparative epigenetic analysis of tumour initiating cells and syngeneic EPSC-derived neural stem cells in glioblastomaVinel C, Rosser G, Guglielmi L, Constantinou M, Pomella N, Zhang X, Boot JR, Jones TA et al.
Nature Communications, Springer Science and Business Media Llc vol. 12 (1)
21-10-2021
Optogenetic modeling of human neuromuscular circuits in Duchenne muscular dystrophy with CRISPR and pharmacological correctionsParedes-Redondo A, Harley P, Maniati E, Ryan D, Louzada S, Meng J, Kowala A, Fu B et al.
Science Advances, American Association For The Advancement of Science (Aaas) vol. 7 (37)
10-09-2021
2019
A new patient‐derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α‐dystroglycanKim J, Lana B, Torelli S, Ryan D, Catapano F, Ala P, Luft C, Stevens E et al.
Embo Reports, Springer Science and Business Media Llc vol. 20 (11)
30-09-2019
Human Induced Pluripotent Stem Cells: Challenges and Opportunities in Developing New Therapies for Muscular DystrophiesParedes‐Redondo A, Lin Y
1-10.
20-03-2019
2017
220th ENMC workshop: Dystroglycan and the dystroglycanopathies Naarden, The Netherlands, 27–29 May 2016Brown SC, Winder SJ, Bevan N, Bevan L, Brown S, van Bokhoven H, Campbell K, Cirak S et al.
Neuromuscular Disorders, Elsevier Bv vol. 27 (4), 387-395.
01-04-2017
CRISPR-mediated genome editing in human induced pluripotent stem cells for modelling FKRP-deficient dystroglycanopathiesKim J, Lana B, Ryan D, Konstantinidis E, Louzada S, Fu B, Yang F, Stemple DL et al.
01-03-2017
Targeted gene correction ofFKRPby CRISPR/Cas9 restores functional glycosylation of α-dystroglycan in cortical neurons derived from human induced pluripotent stem cellsLana B, Kim J, Ryan D, Konstantinidis E, Louzada S, Fu B, Yang F, Stemple DL et al.
In Cold Spring Harbor Laboratory
18-01-2017
Developing novel human isogenic cellular models for Duchenne muscular dystrophyParedes-Redondo A, Lin Y-Y
01-01-2017
2016
The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan additionPraissman JL, Willer T, Sheikh MO, Toi A, Chitayat D, Lin Y-Y, Lee H, Stalnaker SH et al.
Elife, Elife Sciences Publications, Ltd vol. 5
29-04-2016
Functional O‐Mannosylation of α‐Dystroglycan: Trisaccharide‐phospho‐ribitol Primed for Matriglycan AdditionPraissman JL, Willer T, Sheikh MO, Toi A, Chitayat D, Lin Y, Lee H, Stalnaker S et al.
01-04-2016
Isogenic human induced pluripotent stem cell based models for studying FKRP-deficient muscular dystrophyLana B, Ryan D, Konstantinidis E, Muntoni F, Lin Y-Y
01-01-2016
Developing novel human isogenic cellular models for Duchenne muscular dystrophyParedes-Redondo A, Lin Y-Y
01-01-2016
2013
Mutations in GDP-Mannose Pyrophosphorylase B Cause Congenital and Limb-Girdle Muscular Dystrophies Associated with Hypoglycosylation of α-DystroglycanCarss KJ, Stevens E, Foley AR, Cirak S, Riemersma M, Torelli S, Hoischen A, Willer T et al.
The American Journal of Human Genetics, Elsevier Bv vol. 93 (1), 29-41.
01-07-2013
Mutations in B3GALNT2 Cause Congenital Muscular Dystrophy and Hypoglycosylation of α-DystroglycanStevens E, Carss KJ, Cirak S, Foley AR, Torelli S, Willer T, Tambunan DE, Yau S et al.
The American Journal of Human Genetics, Elsevier Bv vol. 92 (3), 354-365.
01-03-2013
Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker–Warburg syndromeBuysse K, Riemersma M, Powell G, van Reeuwijk J, Chitayat D, Roscioli T, Kamsteeg E-J, van den Elzen C et al.
Human Molecular Genetics, Oxford University Press (Oup) vol. 22 (9), 1746-1754.
28-01-2013
Mutations in GDP-Mannose Pyrophosphorylase B Cause Congenital and Limb-Girdle Muscular Dystrophies Associated with Hypoglycosylation of α-DystroglycanCarss KJ, Stevens E, Foley AR, Cirak S, Riemersma M, Torelli S, Hoischen A, Willer T et al.
American Journal of Human Genetics vol. 93 (1), 29-41.
01-01-2013
2012
G.P.1 Validation of novel secondary dystroglycanopathy genes using biochemical, cellular and zebrafish studiesStevens E, Carss K, Cirak S, Torelli S, Foley AR, Sewry C, Topaloglu H, Haliloglu G et al.
01-10-2012
Muscle diseases in the zebrafishLin Y-Y
Neuromuscular Disorders, Elsevier Bv vol. 22 (8), 673-684.
01-08-2012
Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycanRoscioli T, Kamsteeg E-J, Buysse K, Maystadt I, van Reeuwijk J, van den Elzen C, van Beusekom E, Riemersma M et al.
Nature Genetics, Springer Science and Business Media Llc vol. 44 (5), 581-585.
22-04-2012
2011
Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathiesLin Y-Y, White RJ, Torelli S, Cirak S, Muntoni F, Stemple DL
Human Molecular Genetics, Oxford University Press (Oup) vol. 20 (9), 1763-1775.
11-02-2011
2009
Molecular dissection of Drosophila Prickle isoforms distinguishes their essential and overlapping roles in planar cell polarityLin Y-Y, Gubb D
Developmental Biology, Elsevier Bv vol. 325 (2), 386-399.
01-01-2009
Grants
Grants of specific relevance to Predictive in vitro ModelsUnravelling mechanisms of drug-induced myocarditis using immune-responsive human cardiovascular chipYung-Yao Lin and Julien Gautrot
£121,420 MRC Medical Research Council
01-10-2024 - 30-09-2028
Unravelling mechanisms of drug-induced myocarditis using immune-responsive human cardiovascular chipYung-Yao Lin and Julien Gautrot
£20,000 AstraZeneca UK Limited
01-10-2024 - 30-09-2028
Natalia Moreno Sierra NC3R Early Career Engagement AwardYung-Yao Lin
£10,000 NC3Rs National Centre for the Replacement, Refinement and Reduction of Animals in Research
01-02-2024 - 15-06-2024
Engineering Circadian Biology into Human Induced Pluripotent Stem Cell Organ-on-a-Chip modelsDavid Lee and Yung-Yao Lin
£201,874 BBSRC Biotechnology and Biological Sciences Research Council
01-02-2022 - 31-01-2025
Engineering a human microphysiological platform for modelling soft tissue injury and regenerationYung-Yao Lin, Julien Gautrot and John Connelly
£100,000 NC3Rs National Centre for the Replacement, Refinement and Reduction of Animals in Research
06-01-2021 - 16-06-2021
3D bio-printing human pluripotent stem cell-derived skeletal muscle constructs for disease modellingYung-Yao Lin and John Connelly
£91,761 NC3Rs National Centre for the Replacement, Refinement and Reduction of Animals in Research
01-11-2020 - 15-06-2024
Multimodal Comparative Study of Human iPSC-Derived and Primary Skeletal Muscle Progenitor CellsYung-Yao Lin and Charles Knowles
£1,125 King's College London (KCL)
01-07-2020 - 30-06-2021
A microphysiological human 3D neuromuscular platform for modelling DMD and assessing potential therapeuticsYung-Yao Lin
£18,720 Duchenne Parent Project
01-02-2020 - 31-08-2021
Assessing Regenerative Potential Of Myogenic Progenitors Derived From CRISPR-corrected Human IPSCsYung-Yao Lin
£25,320 Action Duchenne
01-10-2018 - 30-09-2019
Assessing regenerative potential of myogenic progenitors derived from CRISPR-corrected human iPSCsYung-Yao Lin
£185,865 Barts and the London Charity
02-04-2018 - 31-03-2023
CRISPR/Cas9 Engineered Human iPSC Models for Muscular Dystrophy ResearchYung-Yao Lin and Andrew Tinker
£490,000 Pfizer Global Pharmaceuticals
14-06-2017 - 31-12-2020